From: Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis
Stage of trial | No. of trials reporting by ethnicity (no. participants) | References | No. of trials reporting as “White”, “BAME”, “non-white”, “Other” (no. participants) | References |
---|---|---|---|---|
Approached for inclusion | 0 | 0 | ||
Screened for inclusion | 0 | 7 (60,179) | ||
Eligible for inclusion | 0 | 7 (60,179) | ||
Ineligible for inclusion | 0 | 7 (60,179) | ||
Enrolled in trial | 17 (52,747) | 11 (64,722) | ||
Followed up at primary endpoint | 0 | 9 (64,434) | ||
Followed up at longest follow-up | 0 | 0 | ||
Effect estimates | 0 | 11 (79,740) |